These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6325759)

  • 1. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
    Yui Y; Kawai C
    Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the treatment of heart failure with captopril].
    Morand P; Lavigne G
    Nouv Presse Med; 1981 Apr; 10(19):1591. PubMed ID: 7025851
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
    Charbonnier B; Monpère C; Desveaux B; Cosnay P; Fauchier JP; Brochier M
    Ann Cardiol Angeiol (Paris); 1984; 33(4):233-7. PubMed ID: 6087714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Favorable hemodynamic effects of captopril in chronic refractory cardiac decompensation].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765277
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress in vasodilator therapy for heart failure.
    Cohn JN
    N Engl J Med; 1980 Jun; 302(25):1414-6. PubMed ID: 6246428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Captopril in the treatment of chronic congestive heart failure].
    Grajek S; Jasiński K
    Kardiol Pol; 1984; 27(3):225-41. PubMed ID: 6376905
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 19. [A clinical study on treatment of refractory heart failure with oral captopril].
    Wang ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitors of angiotensin convertase (inhibitory ACE) in chronic heart failure].
    Kozák P; Salava T; Hes I; Spacek A; Stárek A
    Vnitr Lek; 1987 Feb; 33(2):123-8. PubMed ID: 3029992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.